[1] |
ZHU Yuanchao, ZHANG Yatong, HU Xin.
Principles and measures of medication risk management in the elderly
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1031-1034.
|
[2] |
ZHU Yuanchao, ZHAO Ming, HU Xin, SHI Hong.
Pharmacist-led practice in the management of elderly patients with polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 817-821.
|
[3] |
HUO Peiqiong, ZHENG Peng, SU Zhenhao.
Pharmacovigilance in retail pharmacies for special or major diseases
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 428-432.
|
[4] |
LIU Hongliang, WANG Qing, HOU Yongfang.
Design and implementation of polypharmacy risk data management platform for common diseases of the elderly based on real world data
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1095-1098.
|
[5] |
LIU Bin, SHAO Meiling, CAI Yiran, MA Fengyi, LAN Hong.
Applicability of PDCA cycle in standardization of outpatient prescriptions
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1035-1039.
|
[6] |
ZHAO Xuan, GUO Jing, MEI Long, ZHANG Wei.
Automatic dispensing system on influence of work efficiency of outpatient pharmacy and the safety of prevention and control of COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 564-567.
|
[7] |
CAI Lele, ZHANG Zhuolin, LI Xin, FANG Danjun, HAN Feng.
Research progress in safety and effectiveness of medication of iron deficiency anemia
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1262-1265.
|
[8] |
ZHAO Xuan, GUO Jing, REN Shuang, ZHEN Jiancun.
Management and working modes of outpatient pharmacies amid routine COVID-19 epidemic prevention
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 100-102.
|
[9] |
GENG Hongjiao, WANG Lianxin, XIE Yanming.
Pharmacovigilance of Chinese Medicine in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 552-555.
|
[10] |
ZHANG Yongna, ZHANG Yanjiao, ZHAO Li, HAN Yongxin.
One Case of Drug Treatment and Pharmaceutical Care in Patients with HIT after Coronary Artery Bypass Grafting
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 284-288.
|
[11] |
DONG Min, ZOU Tong, XU Lei, HE Qinghua, PEI Zuowei, WANG Fang.
Effects of Polypharmacy on Long-term Prognosis of Elderly Patients with Coronary Heart Disease and Atrial Fibrillation
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 126-132.
|
[12] |
YANG Juanyan, YANG Fangrong, YANG Shuang, DAI Jiansong, YANG Ling, BAO Gang.
Application of QCC in Improving Monitoring of ADR Reports in a Hospital
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 412-417.
|
[13] |
BAI Shunmin, FAN Zhe.
Improper Prescriptions for Antitumor Drugs in Pharmacy Intravenous Admixture Services
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(4): 239-244.
|
[14] |
LIU Jian, LI Yonghui, LU Ming, ZHANG Yuan.
Analysis of Irrational Medical Advices in Pharmacy Intravenous Admixture Service in A Hospital
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 735-739.
|
[15] |
YANG Chenchen, ZHAO Yinglian, LIU Kai.
Analysis of Unreasonable Prescription Intervention of A Mental Hospital Outpatient Pharmacy from 2016 to 2017
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(12): 751-754.
|